Drug
Sparc1613
Sparc1613: highest development phase Phase 1, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPARC1613 NCT03109249 | Phase 1 | Recurrent or Metastatic Breast Cancer |
Latest
No recent events.
Follow Sparc1613 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.